0067-2040 NDC - EXCEDRIN ()

Drug Information

Product NDC: 0067-2040

Proprietary Name: Excedrin

Non Proprietary Name:

Active Ingredient(s):


Administration Route(s):

Dosage Form(s):

Labeler Information

Labeler Name: GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
Product Type:
FDA Application Number:
Marketing Category:
Start Marketing Date:9/30/2020

Package Information

No. Package Code Package Description Billing Unit
10067-2040-012 TABLET, FILM COATED in 1 POUCH (0067-2040-01)
20067-2040-021 BOTTLE in 1 CARTON (0067-2040-02) / 24 TABLET, FILM COATED in 1 BOTTLE
30067-2040-031 BOTTLE in 1 CARTON (0067-2040-03) / 30 TABLET, FILM COATED in 1 BOTTLE
40067-2040-041 BOTTLE in 1 CARTON (0067-2040-04) / 50 TABLET, FILM COATED in 1 BOTTLE
50067-2040-051 BOTTLE in 1 CARTON (0067-2040-05) / 100 TABLET, FILM COATED in 1 BOTTLE
60067-2040-061 BOTTLE in 1 CARTON (0067-2040-06) / 125 TABLET, FILM COATED in 1 BOTTLE
70067-2040-071 BOTTLE in 1 CARTON (0067-2040-07) / 200 TABLET, FILM COATED in 1 BOTTLE
80067-2040-081 BOTTLE in 1 CARTON (0067-2040-08) / 250 TABLET, FILM COATED in 1 BOTTLE
90067-2040-091 BOTTLE in 1 CARTON (0067-2040-09) / 300 TABLET, FILM COATED in 1 BOTTLE

NDC Record

Field Name Field Value Definition
PRODUCT NDC0067-2040The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEExcedrinThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
PROPRIETARY NAME SUFFIXMigraineA suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard.
START MARKETING DATE9/30/2020This is the date that the labeler indicates was the start of its marketing of the drug product.
LABELER NAMEGlaxoSmithKline Consumer Healthcare Holdings (US) LLCName of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023